Transcriptomic analyses identify association between mitotic kinases, PDZ-binding kinase and BUB1, and clinical outcome in breast cancer Alberto OcañaJavier Pérez-PeñaAtanasio Pandiella Preclinical Study 20 February 2016 Pages: 1 - 8
The prognostic significance of STAT3 in invasive breast cancer: analysis of protein and mRNA expressions in large cohorts Mohammed A. AleskandaranyDevika AgarwalEmad A. Rakha Preclinical study 23 February 2016 Pages: 9 - 20
Whole exome sequencing of rare aggressive breast cancer histologies Maria Vittoria DieciVeronika SmutnáCeline Lefebvre Preclinical Study 23 February 2016 Pages: 21 - 32
Mutations in PIK3CA sensitize breast cancer cells to physiologic levels of aspirin Sanja B. TurturroMatthew S. NajorAbde M. Abukhdeir Preclinical study Open access 25 February 2016 Pages: 33 - 43
Intratumoral estrogen production and actions in luminal A type invasive lobular and ductal carcinomas Mayu TakagiYasuhiro MikiHironobu Sasano Preclinical study 04 March 2016 Pages: 45 - 55
Tristetraprolin mediates the anti-proliferative effects of metformin in breast cancer cells Indira PandiriYingqing ChenJeong Woo Park Preclinical study Open access 08 March 2016 Pages: 57 - 64
MSCs and inflammation: new insights into the potential association between ALCL and breast implants M. OrcianiG. SorgentoniG. Di Benedetto Preclinical Study 08 March 2016 Pages: 65 - 72
A randomized control study of treating secondary stage II breast cancer-related lymphoedema with free lymph node transfer Dimitrios DionyssiouEfterpi DemiriGeorgios Arsos Clinical trial 19 February 2016 Pages: 73 - 79
Prognostic ability of EndoPredict compared to research-based versions of the PAM50 risk of recurrence (ROR) scores in node-positive, estrogen receptor-positive, and HER2-negative breast cancer. A GEICAM/9906 sub-study Miguel MartinJan C. BraseAlvaro Rodriguez-Lescure Clinical trial Open access 24 February 2016 Pages: 81 - 89
Detection of disseminated tumor cells from the bone marrow of patients with early breast cancer is associated with high 21-gene recurrence score Andreas D. HartkopfMarkus WallwienerSara Y. Brucker Clinical trial 25 February 2016 Pages: 91 - 95
Capecitabine and bevacizumab with or without vinorelbine in first-line treatment of HER2/neu-negative metastatic or locally advanced breast cancer: final efficacy and safety data of the randomised, open-label superiority phase 3 CARIN trial A. WeltN. MarschnerS. Hegewisch-Becker Clinical trial Open access 29 February 2016 Pages: 97 - 107
Breast cancer screening using tomosynthesis in combination with digital mammography compared to digital mammography alone: a cohort study within the PROSPR consortium Emily F. ConantElisabeth F. BeaberWilliam E. Barlow Clinical trial 01 March 2016 Pages: 109 - 116
A phase II trial of dose-dense (biweekly) paclitaxel plus carboplatin as neoadjuvant chemotherapy for operable breast cancer T. ZhuC. L. LiuK. Wang Clinical trial 02 March 2016 Pages: 117 - 124
Paclitaxel injection concentrate for nanodispersion versus nab-paclitaxel in women with metastatic breast cancer: a multicenter, randomized, comparative phase II/III study Minish M. JainSmita U. GupteShravanti Bhowmik Clinical trial Open access 03 March 2016 Pages: 125 - 134
Lin28A and androgen receptor expression in ER−/Her2+ breast cancer Honghong ShenYong YangYun Niu Clinical trial 05 March 2016 Pages: 135 - 147
Impact of estrogen receptor-β expression on breast cancer prognosis: a meta-analysis Jieqiong LiuHuishan GuoQiang Liu Epidemiology 22 February 2016 Pages: 149 - 162
Childhood body mass index and adult mammographic density measures that predict breast cancer risk John L. HopperTuong L. NguyenCarmel Apicella Epidemiology 23 February 2016 Pages: 163 - 170
iPrevent®: a tailored, web-based, decision support tool for breast cancer risk assessment and management Ian M. CollinsAdrian BickerstaffeKelly-Anne Phillips Epidemiology Open access 24 February 2016 Pages: 171 - 182
DNA methylation modifies the association between obesity and survival after breast cancer diagnosis Lauren E. McCulloughJia ChenMarilie D. Gammon Epidemiology 05 March 2016 Pages: 183 - 194
Study of breast cancer incidence in patients of lymphangioleiomyomatosis Olivier NuñezAntonio RománMiguel Angel Pujana Epidemiology Open access 07 March 2016 Pages: 195 - 201
Comments on ‘Brief screening of patients with distressing fear of recurrence in breast cancer survivors’ by Akechi et al., Breast Cancer Res Treat, 2015, 153(2): pp. 475–476 B. ThewesM. van de WalJ. Prins Letter to the Editor 25 February 2016 Pages: 203 - 204
Author reply: Brief screening of breast cancer survivors with distressing fear of recurrence Tatsuo AkechiKanae MominoHiroji Iwata Rebuttal Letter 25 February 2016 Pages: 205 - 206
Erratum to: JMJD2A-dependent silencing of Sp1 in advanced breast cancer promotes metastasis by downregulation of DIRAS3 Liliang LiPan GaoJieqing Jiang Erratum 23 February 2016 Pages: 207 - 208
Erratum to: Generation of MCF-7 cells with aggressive metastatic potential in vitro and in vivo Elke ZieglerMarie-Therese HansenCarsten Gründker Erratum 01 March 2016 Pages: 209 - 210